Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway
- Type
- Retraction
- Notice date
- 9/18/2024 0:00
- Journal
- Cancer Cell International
- Publisher
- Springer - Biomed Central (BMC)
- Notice DOI
- 10.1186/s12935-024-03508-w
- Original paper DOI
- 10.1186/s12935-020-01186-y